Health
Study shows benefits of early anticlotting therapy in moderate COVID-19: International RAPID Trial could contribute to clinical practice – Science Daily
New research shows that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with…
COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and is believed to contribute to progression to severe disease and death. New trial results show that administering a full dose of a standard…
Continue Reading
-
General20 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
General10 hours agoMan dies in daylight shooting in Sydney’s north-west
-
Noosa News24 hours agoNew One Nation branch | Noosa Today
-
Noosa News19 hours agoCouncil steps up staff protection after surge in abuse